CompoAtlas

Astaxanthin CoQ10 Seal Oil

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Haematococcus pluvialis

Source : En entier

Extraction ratio : 2:1

Dry plant equivalent : 400 mg

Potency : 1.5 % astaxanthin

200 mgNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : bactéries, levures

60 mgNot calculated
Huile de phoque

Source : Blubber oil from harp seal (Pagophilus groenlandicus)

Potency : 45 mg DHA

500 mgNot calculated
Huile de phoque

Source : Blubber oil from harp seal (Pagophilus groenlandicus)

Potency : 25 mg DPA

Not specifiedNot calculated
Huile de phoque

Source : Blubber oil from harp seal (Pagophilus groenlandicus)

Potency : 35 mg EPA

Not specifiedNot calculated

Non-medicinal ingredients

Tocopherols Excipient NF, Gélatine, Eau purifiée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Softgel capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain and/or support cardiovascular health. Source of antioxidants for the maintenance of good health. Source of DHA, DPA and EPA (Omega-3 fatty acids) for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Nutragenius Inc.
NPN or DIN-HM
80065168
Status
Inactive licence
Licence date
12 November 2015
Revision date
Not provided
Form
Gélule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80065168

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Haematococcus pluvialis
    Read the warning, when it applies and the studies cited

    Haematococcus pluvialis extract

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Eye strain, Eye fatigue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Astaxanthin CoQ10 Seal Oil”, https://compoatlas.com/en/supplements/canada/80065168-astaxanthin-coq10-seal-oil, updated 12 November 2015.

Enter to analyse, Shift+Enter for a new line